GALERA THERAPEUTICS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!About GRTX
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer.
CEOJohn Mel Sorensen
CEOJohn Mel Sorensen
Employees3
Employees3
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2009
Founded2009
Employees3
Employees3
GRTX Key Statistics
Market cap1.97M
Market cap1.97M
Price-Earnings ratio-0.10
Price-Earnings ratio-0.10
Dividend yield—
Dividend yield—
Average volume54.79K
Average volume54.79K
High today$0.0276
High today$0.0276
Low today$0.026
Low today$0.026
Open price$0.0276
Open price$0.0276
Volume51.26K
Volume51.26K
52 Week high$0.1425
52 Week high$0.1425
52 Week low$0.021
52 Week low$0.021
People also own
Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.